<?xml version="1.0" encoding="UTF-8"?>
<p>For oral anticancer therapy in an outpatient setting, follow‐up visits may be minimized to the safest minimum number 
 <xref rid="onco13306-bib-0021" ref-type="ref">21</xref>. Consideration for a chemotherapy break or holiday can be considered on a case‐by‐case basis. To reduce potential viral exposure at pharmacy departments, consideration should be given to the use of a drive‐through medicine collection facility, where patients are alerted by telephone when their medicine is available. Some hospitals may alternatively choose a courier service 
 <xref rid="onco13306-bib-0020" ref-type="ref">20</xref>.
</p>
